September 25, 2012 (Vienna, Austria) — There is still no cure for the common cold, but interferon-β significantly decreases the frequency of cold-induced exacerbations in people with ...

Interferon-Free Treatment: No Longer a Dream? Several studies were presented at both Digestive Disease Week (DDW) 2012 in May and at the European Association for the Study of the Liver (EASL) annual ...

An experimental COVID-19 antiviral appears to be effective at preventing hospitalizations without some of the downsides of other treatments. A study appearing Wednesday in The New England Journal of ...

A new paper from the University of Kansas overturns the idea that a "risk gene" carried by millions of people worldwide ...

SAN FRANCISCO -- A company hoping to market an inhalable formulation of interferon beta for viral lung diseases isn't dissuaded by phase III trial results in 623 hospitalized COVID-19 patients, which ...

Drugs called interferon betas are common treatments for multiple sclerosis (MS), reducing relapses and slowing motor function decline. Interferon beta, a protein known to contain a zinc binding pocket ...

The Covid-19 pandemic is characterized by successive waves of infection driven by variants that have evolved to become more transmissible and immune evasive. Much of the attention has focused on ...

Phase III randomized study to compare interferon alfa-2a in combination with fluorouracil versus fluorouracil alone in patients with advanced colorectal cancer. One hundred six patients with ...

Proceedings of the National Academy of Sciences of the United States of America, Vol. 76, No. 10 (Oct., 1979), pp. 4778-4782 (5 pages) Among the mediators of interferon action are one enzyme that is ...

DUBLIN--(BUSINESS WIRE)--The "Interferon - Biosimilar Insight, 2020" report has been added to ResearchAndMarkets.com's offering. This Interferon-Biosimilar Insight, 2020 report provides comprehensive ...